• Return to Headlines

Insys Therapeuti Down 22.4% Since SmarTrend Downtrend Call (INSY)

By Amy Schwartz

SmarTrend identified a Downtrend for Insys Therapeuti (NASDAQ:INSY) on January 10th, 2018 at $9.31. In approximately 2 months, Insys Therapeuti has returned 22.45% as of today's recent price of $7.22.

Insys Therapeuti share prices have moved between a 52-week high of $19.96 and a 52-week low of $4.10 and are now trading 76% above that low price at $7.22 per share. Over the last five market days, the 200-day moving average (MA) has gone down 2.1% while the 50-day MA has declined 1.3%.

Insys Therapeutics, Inc. develops cancer support drugs. The Company support care candidates include a fast-acting sublingual spray for cancer pain and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Insys Therapeuti.

Log in and add Insys Therapeuti (INSY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights insys therapeuti

Ticker(s): INSY